about
Human subtilase SKI-1/S1P is a master regulator of the HCV Lifecycle and a potential host cell target for developing indirect-acting antiviral agentsPreference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs.In Silico Identification and Conservation Analysis of B-cell and T-Cell Epitopes of Hepatitis C Virus 3a Genotype Enveloped Glycoprotein 2 From Pakistan: A Step Towards Heterologous Vaccine DesignDynamics of HCV RNA levels during acute hepatitis C virus infection.Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infectionNaturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C.Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study.Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort.Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort.Current and emerging antiviral treatments for hepatitis C infectionRole of IL28B gene polymorphism and cell-mediated immunity in spontaneous resolution of acute hepatitis C.Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study.IL28B polymorphisms as a pretreatment predictor of response to HCV treatment.Primary, post-primary and non-specific immunoglobulin M responses in HCV infection.Review of direct-acting antiviral agents for the treatment of chronic hepatitis C.Current trends in the treatment of hepatitis C: interventions to avoid adverse effects and increase effectiveness of anti-HCV drugs.Recommendations for the management of hepatitis C virus infection among people who inject drugs.Next-generation sequencing sheds light on the natural history of hepatitis C infection in patients who fail treatment.Treatment of acute hepatitis C in breast cancer patient: a case report.
P2860
Q31045004-3A402D69-F702-4F80-AB17-F235C64B21F5Q31168171-2989DB0F-F3B2-41FE-801C-31235AF3E427Q33808123-3623C6ED-28AA-4ACF-A1EF-BEA7B364C5CAQ34771346-49E96326-ED35-4C8B-9306-725B96ED1883Q35053399-6C24B7EC-8380-41B4-9D65-D628E1790E96Q35061753-32BF7037-8662-45C8-B009-A8BB34B77C4EQ35249648-B9361C9F-762E-4225-B347-4F201A43333EQ36063808-35065AA8-7352-4FB0-A182-1ACDEECB4DDDQ36200292-7E163476-6DB2-43B1-9118-922FA09E763DQ36729900-69273813-F0FD-4A2B-A7F9-16574324F134Q37111632-613C9A05-15D0-4AD6-AF72-388F235ED729Q37460833-923E8C3C-9AE2-4BF7-9673-A65A14E4D795Q38053543-57610FA0-B1C0-478C-9C93-625BC5846054Q38074373-C379D739-01F9-4AB3-B647-B859BDD4640DQ38111844-B065F3DC-43E6-4DA5-A57C-72C9F0CC3AB8Q39092871-57C0AC14-A065-4273-8435-C85E086C975EQ41047662-CBB317C2-DB5F-4649-AEB0-C5C2F99DAD60Q41940972-8C16077B-A11E-4857-91AB-7FED489D271CQ42232094-16EBA74F-B086-4ACA-B45B-8BC6CB067FC6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of acute HCV infection.
@en
Treatment of acute HCV infection.
@nl
type
label
Treatment of acute HCV infection.
@en
Treatment of acute HCV infection.
@nl
prefLabel
Treatment of acute HCV infection.
@en
Treatment of acute HCV infection.
@nl
P2093
P2860
P356
P1476
Treatment of acute HCV infection.
@en
P2093
Gail V Matthews
Gregory J Dore
Jason Grebely
P2860
P2888
P304
P356
10.1038/NRGASTRO.2011.32
P407
P577
2011-03-22T00:00:00Z